PCN44 COST UTILITY ANALYSIS OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR BREAST CANCER IN THE UK
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63474-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)63474-2/fulltext
Title :
PCN44 COST UTILITY ANALYSIS OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR BREAST CANCER IN THE UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63474-2&doi=10.1016/S1098-3015(10)63474-2
First page :
Section Title :
Open access? :
No
Section Order :
325